Advances in the Management of Refractory Helicobacter pylori Infection: From Antimicrobial Resistance to Precision Eradication
Abstract
Helicobacter pylori infection represents a global public health issue strongly associated with gastric cancer and peptic ulcer disease. Increasing antibiotic resistance has markedly reduced the efficacy of standard eradication regimens, resulting in a growing prevalence of refractory infection and a critical clinical challenge. Refractory H pylori causes substantial patient discomfort and economic costs while worsening antimicrobial resistance. This review summarizes the mechanisms underlying eradication failure and advances in diagnostic approaches from conventional culture to molecular testing. We critically evaluate evidence for personalized salvage therapies based on drug susceptibility and novel acid-suppressive agents including potassium-competitive acid blockers. We propose an integrated clinical framework for diagnosis, treatment, and management and highlight future directions such as new antimicrobials, vaccines, digital health, and global antibiotic stewardship. We stress that a shift from empirical therapy to test-guided precision medicine is essential. Optimized diagnostics, individualized regimens, and comprehensive management will help achieve successful first-line eradication and control the further spread of antibiotic resistance.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.